LON:NIPT Premaitha Health Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Premaitha Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. GBX 9.10 +0.20 (+2.25%) (As of 11/6/2018) Add Compare Share Today's Range 9.10▼ 9.1050-Day Range 9.10▼ 9.1052-Week Range 3.78▼ 14.80Volume1.57 million shsAverage Volume1.35 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsInsider TradesHeadlines Premaitha Health MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.22 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Premaitha Health. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for NIPT. Previous Next 0.0 Dividend Strength Dividend YieldPremaitha Health does not currently pay a dividend.Dividend GrowthPremaitha Health does not have a long track record of dividend growth. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NIPT. Previous Next 1.1 News and Social Media Coverage News SentimentPremaitha Health has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Premaitha Health insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter. Email Address About Premaitha Health (LON:NIPT) StockPremaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.Read More NIPT Stock News HeadlinesJune 26, 2022 | americanbankingnews.comPremaitha Health (LON:NIPT) Stock Price Crosses Above 50 Day Moving Average of $9.10March 6, 2022 | fool.co.ukPersimmon (LSE:PSN)November 10, 2021 | lse.co.ukPremaitha Health Share ChatJanuary 11, 2021 | fool.co.uk(LSE:NIPT)December 23, 2020 | lse.co.ukRecent Broker Ratings for Panmure GordonNovember 28, 2020 | marketwatch.comNon invasive prenatal testing nipt market : Industry Development Scenario and ForecastMay 2, 2020 | finance.yahoo.comHealthcare Industry Trends And Its Impact On Premaitha Health PLC (LON:NIPT)May 2, 2020 | finance.yahoo.comWhat Investors Should Know About Premaitha Health PLC’s (LON:NIPT) Financial StrengthMay 2, 2020 | finance.yahoo.comWas Premaitha Health PLC’s (LON:NIPT) Earnings Growth Better Than The Industry’s?May 2, 2020 | finance.yahoo.comWhy Premaitha Health PLC’s (LON:NIPT) Ownership Structure Is ImportantMay 2, 2020 | finance.yahoo.comIs There Now An Opportunity In Premaitha Health PLC (LON:NIPT)?May 2, 2020 | finance.yahoo.comPremaitha Health PLC’s (LON:NIPT) Shift From Loss To ProfitMay 2, 2020 | finance.yahoo.comWho Owns Premaitha Health PLC (LON:NIPT)?January 17, 2020 | www.benzinga.comNon Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research®January 17, 2020 | www.marketwatch.comNon Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research(R)January 16, 2020 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market Opportunities, Size, Share, Emerging Trends, Technological Innovation And Forecasts To 2025November 18, 2019 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market Precise Study on Factors, Market Drivers and Key Players Strategies Analyzed Till 2025September 23, 2019 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market Is Estimated To Expand At a Healthy CAGR in the Upcoming Forecast 2025September 17, 2019 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market:Overview and scope industry Size,Leading Players and Forecast to 2023August 28, 2019 | www.marketwatch.comGlobal Non-invasive Prenatal Testing (NIPT) Market will grow at a CAGR of 17.5% by 2019-2025June 14, 2019 | www.marketwatch.comGlobal Non-invasive Prenatal Testing Market Will Grow at a Cagr of 17.5% During the Forecast Period 2019-2025See More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:NIPT Previous SymbolLON:VIY CUSIPN/A CIKN/A Webwww.premaitha.com Phone+44-161-6676865FaxN/AEmployeesN/AYear FoundedN/ACompany Calendar Last Earnings12/29/2017Today7/04/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Premaitha Health Frequently Asked Questions How has Premaitha Health's stock performed in 2022? Premaitha Health's stock was trading at GBX 9.10 at the start of the year. Since then, NIPT stock has increased by 0.0% and is now trading at GBX 9.10. View the best growth stocks for 2022 here. How were Premaitha Health's earnings last quarter? Premaitha Health PLC (LON:NIPT) announced its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The firm earned $2.71 million during the quarter. View Premaitha Health's earnings history. Who are Premaitha Health's key executives? Premaitha Health's management team includes the following people: Dr. Stephen Little, Exec. Vice Chairman (Age 61)Mr. Barry Hextall, CFO, Sec. & Exec. DirectorMr. Peter Collins, Chief Bus. Officer & Exec. Director (Age 59)Mr. Lyn Fafydd Rees, CEO & Director (Age 45)Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 42) Who are some of Premaitha Health's key competitors? Some companies that are related to Premaitha Health include [email protected] Technology (LPTC), 1300SMILES (ONT), 1933 Industries (TGIFF), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), 4DMedical (4DX), 4Front Ventures (FFNTF), AB Science (ABSCF), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATT), Abattis Bioceuticals (ATTBF), Abcam (ABCZF), Abzena (ABZA), Acacia Pharma Group (ACPGF) and Acreage (ACRHF). View all of NIPT's competitors. What other stocks do shareholders of Premaitha Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV). What is Premaitha Health's stock symbol? Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT." How do I buy shares of Premaitha Health? Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Premaitha Health's stock price today? One share of NIPT stock can currently be purchased for approximately GBX 9.10. How can I contact Premaitha Health? Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The official website for Premaitha Health is www.premaitha.com. The company can be reached via phone at +44-161-6676865. This page (LON:NIPT) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
